BACKGROUND: Placental malaria is associated with local accumulation of parasitized erythrocytes, deposition of the parasite hemoglobin metabolite, hemozoin, and accumulation of mononuclear cells in the intervillous space. Fetal syncytiotrophoblast cells in contact with maternal blood are known to respond immunologically to cytoadherent Plasmodium falciparum-infected erythrocytes, but their responsiveness to hemozoin, a potent pro-inflammatory stimulator of monocytes, macrophages and dendritic cells, is not known. METHODS: The biochemical and immunological changes induced in primary syncytiotrophoblast by natural hemozoin was assessed. Changes in syncytiotrophoblast mitogen-activated protein kinase activation was assessed by immunoblotting and secreted cytokine and chemokine proteins were assayed by ELISA. Chemotaxis of peripheral blood mononuclear cells was assessed using a two-chamber assay system and flow cytometry was used to assess the activation of primary monocytes by hemozoin-stimulated syncytiotrophoblast conditioned medium. RESULTS: Hemozoin stimulation induced ERK1/2 phosphorylation. Treated cells secreted CXCL8, CCL3, CCL4, and tumor necrosis factor and released soluble intercellular adhesion molecule-1. Furthermore, the dependence of the hemozoin responses on ERK1/2 stimulation was confirmed by inhibition of chemokine release in syncytiotrophoblast treated with an ERK pathway inhibitor. Hemozoin-stimulated cells elicited the specific migration of PBMCs, and conditioned medium from the cells induced the upregulation of intercellular adhesion molecule-1 on primary monocytes. CONCLUSIONS: These findings confirm an immunostimulatory role for hemozoin and expand the cell types known to be responsive to hemozoin to include fetal syncytiotrophoblast. The results provide further evidence that syncytiotrophoblast cells can influence the local maternal immune response to placental malaria.
BACKGROUND:Placental malaria is associated with local accumulation of parasitized erythrocytes, deposition of the parasite hemoglobin metabolite, hemozoin, and accumulation of mononuclear cells in the intervillous space. Fetal syncytiotrophoblast cells in contact with maternal blood are known to respond immunologically to cytoadherent Plasmodium falciparum-infected erythrocytes, but their responsiveness to hemozoin, a potent pro-inflammatory stimulator of monocytes, macrophages and dendritic cells, is not known. METHODS: The biochemical and immunological changes induced in primary syncytiotrophoblast by natural hemozoin was assessed. Changes in syncytiotrophoblast mitogen-activated protein kinase activation was assessed by immunoblotting and secreted cytokine and chemokine proteins were assayed by ELISA. Chemotaxis of peripheral blood mononuclear cells was assessed using a two-chamber assay system and flow cytometry was used to assess the activation of primary monocytes by hemozoin-stimulated syncytiotrophoblast conditioned medium. RESULTS: Hemozoin stimulation induced ERK1/2 phosphorylation. Treated cells secreted CXCL8, CCL3, CCL4, and tumor necrosis factor and released soluble intercellular adhesion molecule-1. Furthermore, the dependence of the hemozoin responses on ERK1/2 stimulation was confirmed by inhibition of chemokine release in syncytiotrophoblast treated with an ERK pathway inhibitor. Hemozoin-stimulated cells elicited the specific migration of PBMCs, and conditioned medium from the cells induced the upregulation of intercellular adhesion molecule-1 on primary monocytes. CONCLUSIONS: These findings confirm an immunostimulatory role for hemozoin and expand the cell types known to be responsive to hemozoin to include fetal syncytiotrophoblast. The results provide further evidence that syncytiotrophoblast cells can influence the local maternal immune response to placental malaria.
Authors: J Ordi; C Menendez; M R Ismail; P J Ventura; A Palacín; E Kahigwa; B Ferrer; A Cardesa; P L Alonso Journal: J Infect Dis Date: 2001-03-08 Impact factor: 5.226
Authors: Elizabeth T Abrams; Heidi Brown; Stephen W Chensue; Gareth D H Turner; Eyob Tadesse; Valentino M Lema; Malcolm E Molyneux; Rosemary Rochford; Steven R Meshnick; Stephen J Rogerson Journal: J Immunol Date: 2003-03-01 Impact factor: 5.422
Authors: Sujittra Chaisavaneeyakorn; Julie M Moore; Lisa Mirel; Caroline Othoro; Juliana Otieno; Sansanee C Chaiyaroj; Ya Ping Shi; Bernard L Nahlen; Altaf A Lal; Venkatachalam Udhayakumar Journal: Clin Diagn Lab Immunol Date: 2003-07
Authors: Douglas J Perkins; Julie M Moore; Juliana Otieno; Ya Ping Shi; Bernard L Nahlen; Venkatachalam Udhayakumar; Altaf A Lal Journal: Biochem Biophys Res Commun Date: 2003-11-28 Impact factor: 3.575
Authors: John W Avery; Geoffrey M Smith; Simon O Owino; Demba Sarr; Tamas Nagy; Stephen Mwalimu; James Matthias; Lauren F Kelly; Jayakumar S Poovassery; Joab D Middii; Carlos Abramowsky; Julie M Moore Journal: PLoS One Date: 2012-02-07 Impact factor: 3.240
Authors: Luciana Vieira de Moraes; Carlos Eduardo Tadokoro; Iván Gómez-Conde; David N Olivieri; Carlos Penha-Gonçalves Journal: PLoS Pathog Date: 2013-01-31 Impact factor: 6.823
Authors: Philippe Boeuf; Elizabeth H Aitken; Upeksha Chandrasiri; Caroline Lin Lin Chua; Bernie McInerney; Leon McQuade; Michael Duffy; Malcolm Molyneux; Graham Brown; Jocelyn Glazier; Stephen J Rogerson Journal: PLoS Pathog Date: 2013-02-07 Impact factor: 6.823
Authors: Manuela Polimeni; Elena Valente; Daniela Ulliers; Ghislain Opdenakker; Philippe E Van den Steen; Giuliana Giribaldi; Mauro Prato Journal: PLoS One Date: 2013-08-14 Impact factor: 3.240